8:30 a.m.

The Changes and Advances in Prostate Cancer, Charles Enke, MD; Jon Morton, MD, FACS; Neil Hansen MD; and Terri Blase, MS, LCGC

The lens through which cancer is being diagnosed, classified and treated is evolving rapidly. Using developments in the diagnosis and treatment of prostate cancer as an example, this session will highlight advances in cancer detection and treatment. New technology such as MR/Ultrasound Fusion biopsy will be highlighted as well as the clinical impact of identifying hereditary gene mutations.

Learning objectives:

1. List two advantages in making a prostate cancer diagnosis using MR/Ultrasound Fusion biopsy technique.
2. Illustrate how eliciting family history and identifying a hereditary gene mutation in patients with prostate cancer can impact medical management.
3. Discuss surgical advances in the treatment of prostate cancer.
4. Describe how multimodal imaging is used in determining the best radiation therapy option for treating prostate cancer. 

10:15 a.m.

Survivorship: The Next Phase of Care, Rachael Schmidt, MSN, APRN

With the seminal report from the Institute of Medicine, “From Cancer Patient to Cancer Survivor: Lost in Transition” in 2006, care of the cancer survivor has become a national priority and has led to the development of multiple models of survivorship. Rachel Schmidt, the nurse practitioner at Nebraska Medicine, who has developed the Survivorship Clinic and care plan at the Fred & Pamela Buffett Cancer Center, will discuss the various models and the steps she used in creating a survivorship program. Her talk will highlight some of the clinical challenges she faces in her patient population. She will also discuss areas for future research in cancer survivorship.

Learning objectives:

1. Describe two models of cancer survivorship care.
2. List the stages of development of a survivorship clinic.
3. Identify future areas for research in cancer survivorship.

11:00 a.m.

Transplantation for Children with Sickle-cell Disease: Current State and Future Direction, Sachit Patel, MD; Rebecca Swanson, MSN, APRN, CPNP; and Amy Brant, BSN, RN

Members of a pediatric stem cell transplant program will conduct a panel discussion on stem cell transplant for children with sickle-cell disease. Team members will discuss the disease’s manifestations and patient characteristics that make stem cell transplant an option for these afflicted children. The discussion will provide a historical perspective of transplant in this patient population, as well as current transplantation strategies. Members will also offer insight into program-specific approaches to this patient population — before, during and after stem cell transplant.

Learning objectives:

1. List two disease manifestations, long-term complications and treatment options for children with sickle-cell disease.
2. Describe the pretransplant process and timeline for evaluation and transplantation in children with sickle-cell disease.
3. Discuss the immediate and post-transplant complications in children undergoing stem cell transplant for sickle-cell disease.

1:00 p.m.

Thyroid Cancer: From Diagnosis to Initial Treatment, Whitney Goldner, MD; Apar Ganti, MD; W. Ken Zhen, MD; and Abbey Fingeret, MD

This year, an estimated 64,300 adults in the United States will be diagnosed with thyroid cancer. It is the most rapidly increasing cancer diagnosis in the U.S. There have been significant advances in the early detection and even more evolution in approaches to the management of the disease. Expert treatment of thyroid cancer is critical to optimal outcomes. A multidisciplinary team approach is the most effective way to address the important decisions surrounding the diagnosis and treatment of thyroid cancer. This presentation will highlight the benefits of such a team for comprehensive care of every patient with a thyroid cancer diagnosis.

Learning objectives:

1. Outline the indications for thyroid nodule biopsy.
2. Recognize different types of thyroid cancer.
3. State the treatment options for thyroid cancer.
4. Define the role of thyroid hormone replacement for persons with thyroid cancer.
5. Identify patients with thyroid cancer who would benefit from targeted therapy.

2:30 p.m.

Autologous Stem Cell Transplantation in Multiple Myeloma (MM): Incorporation of Novel Therapies, Sarah Holstein, MD, PhD

Multiple Myeloma is the second-most-common hematologic malignancy with a wide range of initial presentations. Autologous stem cell transplantation has an important role in the treatment of MM. Treatment options for MM have expanded significantly in the past decade, with novel therapies and treatment strategies being investigated. In this session, Dr. Holstein will review the pathophysiology/epidemiology of myeloma and discuss treatment therapies that have evolved as we have learned more about the disease. She will discuss the role of autologous stem cell transplant and the incorporation of novel drugs and cellular- or vaccine-based strategies in the peritransplant setting.

Learning objectives:

1. Explain the role of autologous stem cell transplant in the era of novel agents.
2. Describe the data supporting the use of post-transplant maintenance therapy.
3. Recognize the investigational drug, cellular, and vaccine strategies that are being incorporated into the transplant setting.

 3:30 p.m.

Improving the Patient Experience: Addressing What Matters Most, Heidi Tonne, BSN, RN, OCN^©; Sue Wardian Hartung, RN, MSN, OCN^®; and Ellie Stull, MSN, RN, OCN

What started as a project to improve our patient satisfaction scores has evolved into an ever-expanding and ongoing journey to improve the overall patient experience. This session will review multiple initiatives that can be undertaken in both the in-patient and outpatient areas to address and improve the patient’s and his/her family’s overall experience while receiving treatment. Engaging patients and families in the discussion and decisions regarding treatment has made these efforts very patient/family centered. One example of an engagement initiative is in the Cancer Care Service’s Patient Family Advisory Council and their impact on the design of the cancer center and some of its programs.

Learning objectives:

1. List two projects utilized in the in-patient setting to improve the patient’s family experience while the patient is receiving treatment in the hospital.
2. Discuss the impact of utilizing the Sacred Moment prior to initiating the patient’s first dose of chemotherapy.
3. Identify two examples of how the Patient Family Advisory Council can impact design plans for a cancer center.